FDA UDI
In Commercial Distribution
🇺🇸 United States
OEM 81-13 Drug Test
DI: 10817038022136
·
Model: U-DOA-654
·
UCP BIOSCIENCES, INC.
Product Codes
5
GMDN Terms
1
Identifiers
3
Pkg Device Count
25
Basic Information
- Brand Name
- OEM 81-13 Drug Test
- Primary DI
- 10817038022136
- Version / Model
- U-DOA-654
- Catalog Number
- U-DOA-654
- Company Name
- UCP BIOSCIENCES, INC.
- Labeler DUNS
- 163610020
- Distribution Status
- In Commercial Distribution
- Device Count in Pkg
- 25
- Record Status
- Published
- Publish Date
- 2023-04-07
- Public Version
- 1
- Public Version Date
- 2023-04-17
- Public Version Status
- New
- Public Device Record Key
- 9509fd22-612d-4972-9387-0b77d8ac6790
- Distribution End Date
- 2033-04-06
Device Description
OEM 81-13 Drug Test 5 Panel Dip Card AMP/COC/THC/MET/BZO
Device Characteristics
- Single Use
- Yes
- Prescription Use (Rx)
- Yes
- Over the Counter (OTC)
- Yes
- Kit
- No
- Combination Product
- No
- HCT/P
- No
- Contains NRL
- No
- Not Made with NRL
- Yes
- MRI Safety
- Labeling does not contain MRI Safety Information
- Direct Marking Exempt
- No
- PM Exempt
- No
- Has Serial Number
- No
- Has Lot/Batch Number
- Yes
- Has Manufacturing Date
- No
- Has Expiration Date
- Yes
- Has Donation ID
- No
Sterilization
- Is Sterile
- No
- Sterilization Prior Use
- No
Product Codes
| Code | Name | Medical Specialty | Regulation # | Device Class |
|---|---|---|---|---|
| DKZ | Enzyme Immunoassay, Amphetamine | Clinical Toxicology | 862.3100 | 2 |
| DIO | Enzyme Immunoassay, Cocaine And Cocaine Metabolites | Clinical Toxicology | 862.3250 | 2 |
| LDJ | Enzyme Immunoassay, Cannabinoids | Clinical Toxicology | 862.3870 | 2 |
| DJC | Thin Layer Chromatography, Methamphetamine | Clinical Toxicology | 862.3610 | 2 |
| JXM | Enzyme Immunoassay, Benzodiazepine | Clinical Toxicology | 862.3170 | 2 |
GMDN Terms
| Code | Name | Definition | Implantable | Status |
|---|---|---|---|---|
| 46994 | Multiple drugs of abuse IVD, kit, rapid ICT, clinical | A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of multiple drugs of abuse in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing. | No | Active |
Identifiers
| Type | ID | Issuing Agency | Package Type | Qty per Pkg | Pkg Status | Pkg Discontinue Date |
|---|---|---|---|---|---|---|
| Package | 20817038022133 | GS1 | case | 50 | Not in Commercial Distribution | 2023-04-06 |
| Primary | 10817038022136 | GS1 | ||||
| Unit of Use | 00817038022139 | GS1 |
Premarket Submissions
| Submission Number | Supplement Number |
|---|---|
| K131811 | 000 |
Storage Conditions
- Type
- Storage Environment Temperature
- Temperature Range
- 2 – 30 Degrees Celsius